TGFB1 and Myocardial fibrosis: The immune response to T. cruzi infection associated with myocardial fibrosis involves TGF-β (Chaves et al., 2019), and this cytokine comprises a therapeutic target in the CD cardiac damage (Waghabi et al., 2022).